Increased cyclin B1/CDC 2 kinase activity and phosphorylation of Bcl-2 associated with paclitaxel-induced apoptosis in human nasopharyngeal carcinoma cells

This publication has 31 references indexed in Scilit:

• Tubulin alterations in taxol-induced apoptosis parallel those observed with other drugs
  Biochemical Pharmacology, 1995
• Evidence for involvement of tyrosine phosphorylation in taxol-induced apoptosis in a human ovarian tumor cell line
  Biochemical Pharmacology, 1994
• Dicing with death: dissecting the components of the apoptosis machinery
  Trends in Biochemical Sciences, 1994
• Cytotoxic studies of paclitaxel (Taxol®) in human tumour cell lines
  British Journal of Cancer, 1993
• Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.
  Proceedings of the National Academy of Sciences, 1993
• Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
  Cell, 1993
• Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer
  JNCI Journal of the National Cancer Institute, 1991
• Microtubule stabilization by taxol inhibits initiation of DNA synthesis by thrombin and by epidermal growth factor
  Cell, 1981
• Taxol stabilizes microtubules in mouse fibroblast cells.
  Proceedings of the National Academy of Sciences, 1980
• Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia
  Journal of the American Chemical Society, 1971